The pharmaceutical sales rep/physician relationship in Turkey: Ethical issues in an international context

Health Marketing Quarterly

Volumn 22, Issue 1, 2004, Pages 21-39

  Tengilimoglu, Dilaver ^a   Kisa, Adnan ^b   Ekiyor, Aykut ^c  

^a GAZI UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c Ankara Provincial Control Laboratory   (Turkey)

Author keywords

Pharmaceutical sales representatives and physician relations; Turkish healthcare system

Indexed keywords

ADULT; ARTICLE; COMMERCIAL PHENOMENA; DRUG INDUSTRY; EMPIRICAL APPROACH; ETHICS; FEMALE; HEALTH CARE AND PUBLIC HEALTH; HEALTH SERVICES RESEARCH; HUMAN; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHYSICIAN; PUBLIC RELATIONS; TURKEY (REPUBLIC);

EMPIRICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ADULT; COMMERCE; DRUG INDUSTRY; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INTERNATIONALITY; INTERPROFESSIONAL RELATIONS; MALE; MIDDLE AGED; PHYSICIANS; TURKEY;

EID: 23044503416     PISSN: 07359683     EISSN: None     Source Type: Journal    
DOI: 10.1300/J026v22n01_03     Document Type: Article

References (15)

1. Atay, O. (2001). Place and Problems of Drugs in Health. Yeni Türkiye Newspaper, Health Special Edition II, Year: 7, Issue: 40, Ankara.
2. Eczacibasi, B. (2001). Political Interventions Should End so as to Be Protected from New Crises, Yeni Türkiye Newspaper, Health Special Edition II, Year: 7, Issue: 40, Ankara.
3. Gaedeke, R. M., Tootelian, D. H., Sanders, E. E. (1999). Value of services provided by pharmaceutical companies: Perceptions of physicians and pharmaceutical sales representatives. Health Marketing Quarterly, 17(1):23-31.
4. Guven, C. K. (1990). Code of Laws Concerning Drug, Istanbul.
5. Kisa, A. (2001a). The performance and problems of the Turkish pharmaceutical industry: Is there a need to develop a national drug policy? Journal of Medical Systems, October; 25(5):309-18.
6. Kisa, A. (2001b). The Turkish Commercial Health Insurance Industry, Journal of Medical Systems, August; 25(4):233-9.
7. Kisa, A. (2002). Financing Healthcare for the Poor: An Examination of the Turkish Green Card Case, Proceedings Book, Editor: David Paul, American Business and Health Administration Association, Chicago, IL, February 27-March 1.
8. Kisa, A., Kavuncubasi, S., & Ersoy, K. (2000). Is the Turkish Social Insurance Organization Ready for the 21st Century, in Proceedings of Local Healthcare, Global Markets: An International Conference on Healthcare Systems for the New Millennium, Ashish Chandra, Editor, 29-32.
9. Kisa, A., Kavuncubasi, S., & Ersoy, K. (2002). Is the Turkish health care system ready to be a part of the European Union? Journal of Medical Systems, April; 26(2):89-95.
10. Lexchin, J. (1993). Interactions Between Physicians and the Pharmaceutical Industry. What Does the Literature Say? Canadian Medical Association Journal, 15 November, (149), Toronto.
11. Savas, B. S. et al. In Thomson, S. & Mossialos, E., eds. (2002). Health care systems in transition: Turkey. WHO, Copenhagen, European Observatory on Health Care Systems, 4(4).
12. Semin S. (1998). Drug in Its Social and Economic Dimension, Turkish Union of Physicians, Ankara.
13. Syndicate of Drug and Chemical Industry Employers. (2000). Activity Report 1999, Mem Ltd.
14. Tengilimoglu, D. & Korkmaz, S. (2000). Sales Management in Drug Marketing: Problems Originated from Relation of Medical Sales Representative and Physician, 5th National Marketing Congress Poster Statement, November 16-18, Antalya.
15. Wall, L. L. & Brown, D. (2002). Pharmaceutical sales representatives and the doctor/patient relationship. Obstetrics and Gynecology. September; 100(3):594-9.